Quarterly Result13 Aug 2026, 02:35 pm
Advik Laboratories Ltd Declares Standalone Un-audited Q1 FY27 Results
AI Summary
Advik Laboratories Ltd (now MPS Pharmaa Limited) announced its standalone un-audited financial results for the quarter ended June 30, 2026. The board meeting, held on August 13, 2026, approved these results and the accompanying limited review report. The company operates in a single segment, pharmaceuticals formulations. Management is actively seeking buyers and exploring new business opportunities to restart operations, with the belief that new deals will be finalized soon.
Key Highlights
- Board approved standalone un-audited financial results for Q1 FY27.
- Limited Review Report for the results was also approved.
- Company operates in a single segment: pharmaceuticals formulations.
- Management is actively pursuing new business opportunities.
- Company expects to finalize new deals soon to restart operations.
Price Impact
More from ADVIKLA